Use in Pregnancy: Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Febuxostat (Urica) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in Lactation: It is not known if Febuxostat (Urica) is excreted in human milk. Since many drugs are excreted in human milk, caution should be exercised when administering Febuxostat (Urica) to breastfeeding women.
Other Services
Country
Account